Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

EU HTA Publication Digest: Paving the road for a successful EU HTA Reform implementation

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. 

In a recent publication, Severens et al. analyzed Europe-wide perspectives on the implementation of the EU HTA Regulation, mapping key implementation challenges and proposing actions to support a smoother transition. The authors highlighted wide variation in national preparedness, concerns about sovereignty, and the need to streamline processes while expanding Joint Scientific Consultation capacity. Their analysis underscored that stronger cross-country collaboration and deeper stakeholder engagement are essential to ensure effective EU HTAR implementation and improved access to innovative technologies.

Access the full-text article here.